Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones
暂无分享,去创建一个
R. Loddo | C. Ibba | P. la Colla | Anna Bielenica | M. Struga | J. Kossakowski | I. Dybała | Cristina Ibba
[1] S. Kabilan,et al. Design and synthesis of novel piperazine unit condensed 2,6-diarylpiperidin-4-one derivatives as antituberculosis and antimicrobial agents , 2012, Medicinal Chemistry Research.
[2] R. Loddo,et al. Biological evaluation of novel 1,4-dithiine derivatives as potential antimicrobial agents , 2011, Medicinal Chemistry Research.
[3] P. Manisankar,et al. Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives. , 2010, European journal of medicinal chemistry.
[4] C. Pannecouque,et al. A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication. , 2010, Journal of medicinal chemistry.
[5] R. Loddo,et al. Synthesis and Evaluation of in Vitro Biological Activity of 4-Substituted Arylpiperazine Derivatives of 1,7,8,9-Tetrachloro-10,10-dimethoxy-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione , 2009, Molecules.
[6] R. Loddo,et al. Biological evaluation of 10-(diphenylmethylene)- 4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione derivatives , 2009, Central European Journal of Biology.
[7] R. Araya-Maturana,et al. Synthesis of 2‐Benzothienyl Carbonyl 4‐Arylpiperazines as Novel Delavirdine Analogs , 2007 .
[8] S. Nimesh,et al. Synthesis, characterization and in vitro biological studies of novel cyano derivatives of N-alkyl and N-aryl piperazine. , 2007, European journal of medicinal chemistry.
[9] P. Yogeeswari,et al. Synthesis and in vitro anti-HIV activities of didanosine prodrugs , 2007, Journal of enzyme inhibition and medicinal chemistry.
[10] K. Kuhen,et al. Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[11] Ramesh Chandra,et al. Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives. , 2006, Bioorganic & medicinal chemistry.
[12] A. Shafiee,et al. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives. , 2005, Bioorganic & medicinal chemistry letters.
[13] A. Bojarski,et al. New imide 5-HT1A receptor ligands - modification of terminal fragment geometry. , 2004, Molecules.
[14] Silvio Massa,et al. Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant. , 2004, Journal of medicinal chemistry.
[15] G. Marshall,et al. Design, synthesis and QSAR studies on N-aryl heteroarylisopropanolamines, a new class of non-peptidic HIV-1 protease inhibitors. , 2002, Bioorganic & medicinal chemistry.
[16] P. la Colla,et al. Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties. , 2001, Chemical & pharmaceutical bulletin.
[17] G. Boiteau,et al. J. Virol. Methods , 1996, Journal of Virological Methods.
[18] J. Maguire,et al. Colorimetric hydroxylamine-iron (III) methods for studies of the enzymatic hydrolyses of cyclic imides and of amic acids. , 1977, Analytical chemistry.
[19] V. Jain,et al. SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL SCREENING OF SOME 4- SUBSTITUTED 1(4SUBSTITUTED PHENYL) PIPERAZINE DERIVATIVES , 2011 .
[20] H. Pessoa‐Mahana,et al. Synthesis of a novel series of 4-arylpiperazinyl derivatives linked to a 2-(pyridin-3-yl)-1H-benzimidazole as new Delavirdine analogues , 2010 .
[21] L. Di,et al. Chapter 4 – Rules for Rapid Property Profiling from Structure , 2008 .
[22] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[23] F. Hadizadeh,et al. Synthesis of Some New 1-(2-(alkylthio-1-benzyl-5- imidazolyl) carbonyl)-4-(3-(isopropylamino)-2-pyridyl) piperazines as Anti-HIV , 2004 .